Medsafe restricts sodium valproate prescribing to protect unborn babies from birth defects

+Print Archive
NEWS

Medsafe restricts sodium valproate prescribing to protect unborn babies from birth defects

Chris James
Medsafe group manager Chris James says a clearer picture is emerging about the risks to unborn babies posed by sodium valproate
Medsafe has tightened restrictions on the use of sodium valproate to treat bipolar disorder. This follows ACC’s increasing concerns about the drug,, Conporto, A screen shot of the Conporto analytic tool which detected sodium valproate prescribed in general practice without a contraceptive prescription